Genexol-PM is an investigational drug.
There have been 18 clinical trials for Genexol-PM.
The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2009.
The most common disease conditions in clinical trials are Breast Neoplasms, Ovarian Neoplasms, and Carcinoma, Ovarian Epithelial. The leading clinical trial sponsors are Samyang Biopharmaceuticals Corporation, Gachon University Gil Medical Center, and Asan Medical Center.